![](/img/cover-not-exists.png)
A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors
Smith, D. C., Eisenberg, P. D., Manikhas, G., Chugh, R., Gubens, M. A., Stagg, R. J., Kapoun, A. M., Xu, L., Dupont, J., Sikic, B.Volume:
20
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-14-1373
Date:
December, 2014
File:
PDF, 785 KB
english, 2014